Non-invasive fetal RhD genotyping (4268 DK)

The program is used for external quality assurance of non-invasive fetal Rhesus D genotyping.
The target group is clinical immunology departments.
There is two rounds of 2 samples annually.

Reports are available at no later then 15 weekdays after the deadline for reporting results.

Here you find useful information about the program:

If you have any questions, please contact program coordinator chemist Morten Pedersen,